Project Grant HT94252510012
Award Date
3/1/25
Completion Date
2/28/27
Dollars Obligated
$363K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The Regents of the University of Minnesota were awarded a $3.7 million project grant from the Department of the Army Medical Command's Military Medical Research and Development program to develop biologically engineered growing heart conduits from June 15, 2022 through June 14, 2026. Through this funding, the University will conduct research to biologically engineer heart tissue that can grow as a child develops, aiming to provide an alternative to current artificial heart valves or conduits for...
This $317,001 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will support the University of Texas at Austin's investigation of clot mechanics in pulmonary failure and thromboembolic disease in sickle cell anemia. The research aims to improve understanding and treatment of these conditions, which are of high relevance to military medicine. The 2-year project will leverage the university's...
The University of Texas Southwestern Medical Center was awarded a $1,639,308 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2025 to repurpose MEK-inhibitors for the treatment of lymphatic malformations. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through...
This $804,372 Project Grant awarded by the Defense Health Agency on August 15, 2023 supports research by Duke University to examine the impact of alpha-gal syndrome on early bioprosthetic heart valve degradation. The research is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve health outcomes for service members and veterans. The project will be conducted over a 2-year period, with a...
The University of Texas Southwestern Medical Center received a $1,334,865 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from September 2021 through August 2025 to target lymphatics in the treatment of trauma-induced heterotopic ossification. Through this funding, the awardee will investigate medical solutions for traumatic injuries commonly experienced by military Service Members on the...
This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...
The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health care...
The Defense Health Agency awarded a $312,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the role of neural crest progenitors in the development of ventricular outflow tract defects. The three-year award beginning March 1, 2021 will support applied biomedical research focused on exploring medical solutions for congenital heart defects through innovative investigation of embryonic...
The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...